These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1949932

  • 1. Altered absorption of digoxin, sustained-release quinidine, and warfarin with sucralfate administration.
    Rey AM, Gums JG.
    DICP; 1991; 25(7-8):745-6. PubMed ID: 1949932
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of the digoxin-quinidine interaction via mixed-effect modelling.
    Williams PJ, Lane J, Murray W, Mergener MA, Kamigaki M.
    Clin Pharmacokinet; 1992 Jan; 22(1):66-74. PubMed ID: 1559308
    [Abstract] [Full Text] [Related]

  • 3. Apparent quinidine-induced digoxin toxicity after withdrawal of pentobarbital: a case of sequential drug interactions.
    Chapron DJ, Mumford D, Pitegoff GI.
    Arch Intern Med; 1979 Mar; 139(3):363-5. PubMed ID: 426582
    [Abstract] [Full Text] [Related]

  • 4. Increased absorption of digoxin from the human jejunum due to inhibition of intestinal transporter-mediated efflux.
    Igel S, Drescher S, Mürdter T, Hofmann U, Heinkele G, Tegude H, Glaeser H, Brenner SS, Somogyi AA, Omari T, Schäfer C, Eichelbaum M, Fromm MF.
    Clin Pharmacokinet; 2007 Mar; 46(9):777-85. PubMed ID: 17713975
    [Abstract] [Full Text] [Related]

  • 5. Mixed-effect modeling for detection and evaluation of drug interactions: digoxin-quinidine and digoxin-verapamil combinations.
    Bauer LA, Horn JR, Pettit H.
    Ther Drug Monit; 1996 Feb; 18(1):46-52. PubMed ID: 8848820
    [Abstract] [Full Text] [Related]

  • 6. Alteration of digoxin pharmacokinetics by a single dose of quinidine.
    Chen TS, Friedman HS.
    JAMA; 1980 Aug 15; 244(7):669-72. PubMed ID: 6156244
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic and pharmacodynamic drug-drug interaction assessment between pradigastat and digoxin or warfarin.
    Yan JH, Meyers D, Lee Z, Danis K, Neelakantham S, Majumdar T, Rebello S, Sunkara G, Chen J.
    J Clin Pharmacol; 2014 Jul 15; 54(7):800-8. PubMed ID: 24619917
    [Abstract] [Full Text] [Related]

  • 8. Use of control steady-state serum digoxin levels for predicting serum digoxin concentration after quinidine administration.
    Friedman HS, Chen TS.
    Am Heart J; 1982 Jul 15; 104(1):72-6. PubMed ID: 6178280
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic Interactions Between Mirabegron and Metformin, Warfarin, Digoxin or Combined Oral Contraceptives.
    Groen-Wijnberg M, van Dijk J, Krauwinkel W, Kerbusch V, Meijer J, Tretter R, Zhang W, van Gelderen M.
    Eur J Drug Metab Pharmacokinet; 2017 Jun 15; 42(3):417-429. PubMed ID: 27350625
    [Abstract] [Full Text] [Related]

  • 10. Quinidine: an update on therapeutics, pharmacokinetics and serum concentration monitoring.
    Crevasse L.
    Am J Cardiol; 1988 Nov 03; 62(14):22I-23I. PubMed ID: 3189164
    [Abstract] [Full Text] [Related]

  • 11. Sevelamer hydrochloride (Renagel), a nonabsorbed phosphate-binding polymer, does not interfere with digoxin or warfarin pharmacokinetics.
    Burke S, Amin N, Incerti C, Plone M, Watson N.
    J Clin Pharmacol; 2001 Feb 03; 41(2):193-8. PubMed ID: 11210401
    [Abstract] [Full Text] [Related]

  • 12. Digoxin-quinidine and digoxin-amiodarone interactions: frequency of occurrence and monitoring in Australian repatriation hospitals.
    Freitag D, Bebee R, Sunderland B.
    J Clin Pharm Ther; 1995 Jun 03; 20(3):179-83. PubMed ID: 7593381
    [Abstract] [Full Text] [Related]

  • 13. Effect of Semaglutide on the Pharmacokinetics of Metformin, Warfarin, Atorvastatin and Digoxin in Healthy Subjects.
    Hausner H, Derving Karsbøl J, Holst AG, Jacobsen JB, Wagner FD, Golor G, Anderson TW.
    Clin Pharmacokinet; 2017 Nov 03; 56(11):1391-1401. PubMed ID: 28349387
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of the intestinal digoxin absorption and exsorption by quinidine.
    Su SF, Huang JD.
    Drug Metab Dispos; 1996 Feb 03; 24(2):142-7. PubMed ID: 8742224
    [Abstract] [Full Text] [Related]

  • 15. Interaction between quinidine and digoxin.
    Leahey EB, Reiffel JA, Drusin RE, Heissenbuttel RH, Lovejoy WP, Bigger JT.
    JAMA; 1978 Aug 11; 240(6):533-4. PubMed ID: 671662
    [Abstract] [Full Text] [Related]

  • 16. Multiple doses of the antimuscarinic agent solifenacin do not affect the pharmacodynamics or pharmacokinetics of warfarin or the steady-state pharmacokinetics of digoxin in healthy subjects.
    Smulders RA, Kuipers ME, Krauwinkel WJ.
    Br J Clin Pharmacol; 2006 Aug 11; 62(2):210-7. PubMed ID: 16842396
    [Abstract] [Full Text] [Related]

  • 17. Impairment of digoxin clearance by coadministration of quinidine.
    Ochs HR, Bodem G, Greenblatt DJ.
    J Clin Pharmacol; 1981 Oct 11; 21(10):396-400. PubMed ID: 7309901
    [Abstract] [Full Text] [Related]

  • 18. Digoxin bioavailability during quinidine administration.
    Hager WD, Mayersohn M, Graves PE.
    Clin Pharmacol Ther; 1981 Nov 11; 30(5):594-9. PubMed ID: 7297019
    [Abstract] [Full Text] [Related]

  • 19. Effects of quinidine and disopyramide on serum digoxin concentrations.
    Manolas EG, Hunt D, Sloman G.
    Aust N Z J Med; 1980 Aug 11; 10(4):426-9. PubMed ID: 6932834
    [Abstract] [Full Text] [Related]

  • 20. Quinidine and digoxin. An important interaction.
    Bigger JT, Leahey EB.
    Drugs; 1982 Sep 11; 24(3):229-39. PubMed ID: 6751790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.